IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Players See Strong Demand for TNF Inhibitors, TMR Report Notes

  • The IBD (ulcerative colitis and Crohn’s disease) treatment market is expected to exceed a value of US$34.22 billion by 2031
  • Rise in Ulcerative Colitis Cases Globally Opens Growth Opportunities in IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market

WILMINGTON, Del., July 20, 2022 /PRNewswire/ — A research report by Transparency Market Research (TMR) predicts that the global IBD treatment market will grow at a CAGR of 6.8% during the forecast period from 2022 to 2031.

Several manufacturers of treatments for IBD (ulcerative colitis and Crohn’s disease) offer attractive reimbursement plans to support healthcare costs. Such initiatives should have a positive impact on patients’ feelings regarding the effective treatment of this disease. This factor, in turn, is expected to drive the demand for IBD (ulcerative colitis and Crohn’s disease) treatment solutions in the coming years.

Doctors around the world are inclined to prescribe TNF inhibitors for the treatment of moderate to critical ulcerative colitis. As a result, R&D investments focused on TNF inhibitors have increased, analysts note in a TMR report on the IBD (ulcerative colitis and Crohn’s disease) treatment market.

Request IBD Treatment Market Research Report Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1473

IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market: Key Findings

  • The number of patients worldwide suffering from Inflammatory Bowel Disease (IBD) is increasing globally in recent years. This factor opens notable growth prospects for the IBD (ulcerative colitis and Crohn’s disease) treatment market.
  • The global IBD (ulcerative colitis and Crohn’s disease) treatment market is driven by factors such as increasing approvals of new biologic drugs for IBD and increasing usage of IBD treatment solutions in several emerging economies. Thus, the IBD (ulcerative colitis and Crohn’s disease) treatment market is expected to be valued at more than US$34.22 billion by 2031.

Demand for Analysis of Impact of COVID-19 on IBD Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1473

IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market: Growth Boosters

  • Rising prevalence of ulcerative colitis in many developed and developing countries is driving sales growth in IBD (ulcerative colitis and Crohn’s disease) treatment market
  • The surge in adoption of TNF inhibitors due to their high level of efficacy, improved therapeutic outcomes and safety is driving the sales growth in the market
  • The growing propensity of people to use biosimilar or biologic drugs is expected to create opportunities in the IBD (ulcerative colitis and Crohn’s disease) treatment market

Get Exclusive Sample PDF Copy of IBD Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1473

IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market: Regional Analysis

  • The market for the treatment of IBD (ulcerative colitis and Crohn’s disease) in North America is expected to maintain its dominance over the forecast period due to an increase in the prevalence of Crohn’s disease and ulcerative colitis in Canada and the United States. Additionally, the regional market is expected to grow at a steady pace owing to the presence of strong healthcare infrastructure and rising incidence of lifestyle disorders among the people of North America.
  • The market in Latin America and Middle East & Africa is expected to increase at a notable CAGR during the forecast period owing to an increase in the number of IBD patients across the regions. Additionally, the market in these regions is expected to grow owing to the growing focus of regional market players on the development of next-generation therapies.

Inquire Before You Buy – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1473

IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market: Key Players

Some of the key players profiled in the report are:

  • Janssen Biotech, Inc. (Johnson & Johnson)
  • Pfizer, Inc.
  • Allergan AG
  • Health Companies, Inc.
  • AbbVie, Inc.
  • Takeda Pharmaceutical Company Limited
  • UCB, Inc.
  • Novartis AG
  • Biogene, Inc.

IBD (ulcerative colitis and Crohn’s disease) treatment market segmentation

  • Drug class
    • TNF inhibitors
    • Aminosalicylates
    • Integrin antagonists
    • Corticosteroids
    • Others
  • Indication of the disease
    • Ulcerative colitis
    • Crohn’s disease
  • Distribution channel
    • Hospital pharmacies
    • Retail pharmacies
    • Online pharmacies
  • Regions covered
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Modernization of healthcare in terms of infrastructure and services has pushed the healthcare industry to new heights, stay updated with Latest Healthcare Research Reports by Transparency Market Research:

Drug Addiction Treatment Market: The global drug addiction treatment market was valued at US$6.2 billion in 2019 and is expected to grow at a CAGR of around 6% from 2020 to 2030.

Bruise Treatment Market: The global bruise treatment market is expected to reach more than US$444 million by the end of 2031. The global market is expected to expand at a CAGR of 3.5% from 2022 to 2031.

Venous Disease Treatment Market: Rising awareness in the treatment of deep vein thrombosis, treatment of chronic vein occlusions, treatment of venous insufficiency and treatment of leg ulcers; and growing number of product approvals are driving the market.

Pressure Ulcer Treatment Market: Rising prevalence of pressure ulcers, rising prevalence of chronic diseases, and technological advancements in wound care are expected to propel the global pressure ulcer treatment market over the forecast period.

Drug Addiction Treatment Market: Rising awareness about the negative effects of drug addiction, introduction of new programs and increase in the number of rehabilitation centers globally are expected to contribute to the growth of the global market.

Chronic Pelvic Pain Treatment Market: Growth in adoption of new treatment procedures such as acupuncture, chiropractic care, biofeedback therapy, and behavioral therapy is expected to drive the global pelvic pain treatment market chronic.

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Rising adoption of digital inhalers and triple therapy treatment options are expected to create additional opportunities for manufacturers in the COPD treatment market during the forecast period.

Psoriasis Treatment Market: Rising Number of Psoriasis Patients, Approval of New Psoriasis Biologic Drugs, New Drug Pipeline, and Increasing Access to Psoriasis Treatment in Developing Countries are expected to propel the global psoriasis treatment market.

About Transparency Market Research

Transparency Market Research, a global market research firm registered in Wilmington, Delaware, United States, provides personalized research and consulting services. Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.

For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Office 1200, Wilmington, Delaware 19801 United States
Tel: +1-518-618-1030
UNITED STATES – Canada toll-free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
E-mail: [email protected]

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

SOURCE Transparency Market Research

Source link

About Chris Y. Camp

Check Also

US sues Idaho over abortion law, cites medical treatment

BOISE, Idaho (AP) — The Justice Department on Tuesday filed a lawsuit challenging Idaho’s restrictive …